Early Detection of Vaping-related Vascular Diseases

Part of paid clinical trials in Miami, Florida.

Sponsor
University of Miami
Study ID
NCT05454267
Status
Recruiting
Apply to this trial

Conditions

  • Blood Vessel Injury
  • Vaping

Eligibility Criteria

Sex
ALL
Age
18 Years - 40 Years
Healthy Volunteers
Accepted

Study Details

The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.

Key Dates

Start date
Sep 12, 2022
Status verified
May 2026
Primary completion
Jun 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
90 participants (estimated)

Arms

  • Arm: Healthy Volunteer Group
    Participants who have never smoked or vaped
  • Arm: High Frequency Vaping Group
    Participants who vape \>20 days per month.
  • Arm: Low-Frequency Vaping Group
    Participants who vape \< 20 days per month

Primary Outcome Measure

Airway blood flow reactivity (QAW) [ Time Frame: Up to 1 week ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Miami Health SystemMiamiFlorida33136
Michael Campos, MD
[email protected]
3052436388
Adam Wanner, MD (PRINCIPAL_INVESTIGATOR)
Michael Campos, MD (SUB_INVESTIGATOR)
Barry Hurwitz, MD (SUB_INVESTIGATOR)
Taghrid Asfar, MD (SUB_INVESTIGATOR)

Find similar trials in Miami, FL

By research site
University of Miami Health System· Miami, FL

Related Studies